Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO – biolegacy

Athenex, A US-China Cancer Company, Stages $66 Million U.S. IPO

Post author:Sam
Post published:June 15, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace